rs701848

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000314.8(PTEN):​c.*1516T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.359 in 218,680 control chromosomes in the GnomAD database, including 15,307 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9528 hom., cov: 24)
Exomes 𝑓: 0.39 ( 5779 hom. )

Consequence

PTEN
NM_000314.8 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.32

Publications

59 publications found
Variant links:
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
PTEN Gene-Disease associations (from GenCC):
  • Cowden syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • PTEN hamartoma tumor syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • macrocephaly-autism syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • leiomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • activated PI3K-delta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bannayan-Riley-Ruvalcaba syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lhermitte-Duclos disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Proteus-like syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • glioma susceptibility 2
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 10-87966988-T-C is Benign according to our data. Variant chr10-87966988-T-C is described in ClinVar as Benign. ClinVar VariationId is 301463.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.62 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000314.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTEN
NM_000314.8
MANE Select
c.*1516T>C
3_prime_UTR
Exon 9 of 9NP_000305.3
PTEN
NM_001304717.5
c.*1516T>C
3_prime_UTR
Exon 10 of 10NP_001291646.4
PTEN
NM_001304718.2
c.*1516T>C
3_prime_UTR
Exon 9 of 9NP_001291647.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTEN
ENST00000371953.8
TSL:1 MANE Select
c.*1516T>C
3_prime_UTR
Exon 9 of 9ENSP00000361021.3P60484-1
PTEN
ENST00000693560.1
c.*1516T>C
3_prime_UTR
Exon 10 of 10ENSP00000509861.1A0A8I5KSF9
PTEN
ENST00000688158.2
n.3463T>C
non_coding_transcript_exon
Exon 11 of 11

Frequencies

GnomAD3 genomes
AF:
0.341
AC:
49462
AN:
145100
Hom.:
9530
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.152
Gnomad AMI
AF:
0.506
Gnomad AMR
AF:
0.348
Gnomad ASJ
AF:
0.341
Gnomad EAS
AF:
0.424
Gnomad SAS
AF:
0.637
Gnomad FIN
AF:
0.447
Gnomad MID
AF:
0.276
Gnomad NFE
AF:
0.409
Gnomad OTH
AF:
0.323
GnomAD4 exome
AF:
0.394
AC:
28976
AN:
73494
Hom.:
5779
Cov.:
0
AF XY:
0.398
AC XY:
13549
AN XY:
34062
show subpopulations
African (AFR)
AF:
0.150
AC:
503
AN:
3352
American (AMR)
AF:
0.350
AC:
773
AN:
2206
Ashkenazi Jewish (ASJ)
AF:
0.361
AC:
1636
AN:
4536
East Asian (EAS)
AF:
0.431
AC:
4540
AN:
10538
South Asian (SAS)
AF:
0.653
AC:
422
AN:
646
European-Finnish (FIN)
AF:
0.515
AC:
239
AN:
464
Middle Eastern (MID)
AF:
0.336
AC:
150
AN:
446
European-Non Finnish (NFE)
AF:
0.409
AC:
18454
AN:
45166
Other (OTH)
AF:
0.368
AC:
2259
AN:
6140
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
836
1673
2509
3346
4182
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.341
AC:
49456
AN:
145186
Hom.:
9528
Cov.:
24
AF XY:
0.349
AC XY:
24459
AN XY:
70168
show subpopulations
African (AFR)
AF:
0.151
AC:
5972
AN:
39432
American (AMR)
AF:
0.347
AC:
4854
AN:
13970
Ashkenazi Jewish (ASJ)
AF:
0.341
AC:
1169
AN:
3428
East Asian (EAS)
AF:
0.424
AC:
2104
AN:
4968
South Asian (SAS)
AF:
0.639
AC:
2934
AN:
4590
European-Finnish (FIN)
AF:
0.447
AC:
3948
AN:
8836
Middle Eastern (MID)
AF:
0.273
AC:
77
AN:
282
European-Non Finnish (NFE)
AF:
0.409
AC:
27307
AN:
66784
Other (OTH)
AF:
0.319
AC:
636
AN:
1996
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1442
2885
4327
5770
7212
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
510
1020
1530
2040
2550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.267
Hom.:
1106
Bravo
AF:
0.320
Asia WGS
AF:
0.470
AC:
1624
AN:
3466

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
-
-
1
PTEN hamartoma tumor syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
16
DANN
Benign
0.85
PhyloP100
2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs701848; hg19: chr10-89726745; COSMIC: COSV64293119; API